cTIV

BIOLOGICAL2 trials

Sponsors

Novartis Vaccines, Novavax

Conditions

InfluenzaSeasonal Influenza Vaccine

Phase 2

A Study to Evaluate the Immune Response and Safety of a Seasonal Virus-Like Particle Influenza Vaccine in Healthy Young Adults

CompletedNCT01561768

NovavaxInfluenza

Start: 2012-03-31End: 2013-01-31Updated: 2013-07-18

Phase 3

Safety and Immunogenicity of Trivalent Subunit Influenza Vaccine Produced in Mammalian Cell Culture Using the Strain Composition 2007/2008

CompletedNCT00511914

Novartis VaccinesSeasonal Influenza Vaccine

Start: 2007-07-31End: 2007-08-31Updated: 2013-01-24